Precancer? Earliest cancer? Milk-duct cells vexing
The formal name less scary could help, says a new report that urges the elimination of the word “cancer” in the diagnosis of common growth in the milk ducts.
More than 50,000 women a year are diagnosed with ductal carcinoma in situ or ductal carcinoma in situ. Not invasive breast cancer, the kind that kills. The abnormal cells have not left the milk duct to penetrate the breast tissue.
However, because it removes a risk factor for developing invasive cancer later true. Treatment works. Only about 2 percent of patients with ductal carcinoma in situ of dying from breast cancer in the next 10 years.
The problem: Doctors have no good way to say that women are at risk for DCIS as cancer again and that really are not. So there are big differences in how it is, a simple small surgery to a total radiation and blast of chemotherapy. Some women even have removed the healthy contralateral breast protector.
It is time for research to answer the question of risk and determine with certainty that could jump harsh treatment and that he really needs, concluded experts convened by the National Institutes of Health to assess DCIS.
And change the name, the panel concluded, will help doctors say that while this growth should not be ignored, no time to carefully consider the options.
“The name brings with it a disproportionate level of anxiety in relation to the indolent nature of the disease,” said Dr. Carmen Allegra, University of Florida, an oncologist, who chaired the panel.
The panel did not offer an alternative name.
But the problem is similar to cervical cancer which abnormal cells form in the surface of the cervix early invader. What doctors now call a precancerous condition – and sort through various levels of gravity – when called cervical carcinoma in situ.
With ductal carcinoma in situ, “This is a complex issue that know less about,” said Dr. Susan Reed of Seattle’s Fred Hutchinson Cancer Research Center. “We have a clear idea of how you say, for example, ‘Mrs. Jones, the risk of getting invasive breast cancer over the next 10 years would be” some percentage”.